NEW YORK–(BUSINESS WIRE)–Universal Marine Medical Supply International, the leading global provider of pharmaceutical and medical solutions to the maritime industry, today announced the appointment of Simon Stadil as Chief Financial Officer, effective April 1.
Mr. Stadil brings over 15 years of extensive experience in commercial finance, finance operations, product distribution economics, and IT and digital transformation to his new role. He possesses significant knowledge of the maritime and shipping industries from his tenure in both public and private equity-backed companies, excelling in high-growth environments through the implementation of transformative strategies to scale businesses. As CFO, he will support Unimed’s continued growth as a close business partner to CEO Søren Andersen and the Company’s Board, focusing on driving value creation across all divisions of the business and executing financial strategies to facilitate decision-making processes.
“I’m thrilled to welcome Simon to the Unimed management team. He is an ambitious and driven leader with diverse finance experience,” said Søren Andersen, CEO of Unimed. “His demonstrated success at multiple international companies will support our strategic decision-making and advance our value-creation goals as we continue to grow and scale globally.”
“Unimed has an enormous opportunity to continue transforming how the maritime industry protects health at sea,” Mr. Stadil said. “With its reputation for product quality and digital innovation, I look forward to working with Søren, the Board, and our partners at ZCG to strengthen Unimed’s leadership as a trusted maritime supplier of pharmaceutical and medical solutions.”
“Simon has demonstrated his ability to profitably grow technology-enabled supply management and distribution service companies globally, and his appointment brings valuable experience to the Unimed team,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “With his valuable experience, Unimed can continue to grow internationally, leveraging its innovative and client-focused technologies to achieve continued success.”
Prior to joining Unimed, Mr. Stadil served as CFO of LiqTech International, Inc., a Nasdaq-listed global supplier of advanced silicon carbide filtration solutions supporting the maritime and offshore industries, where he oversaw the company’s finance, legal, administrative and IT departments. Before that, he spent 8 years at Welltec, most recently serving as Vice President of Global Finance, where he led the company’s global finance function across more than 25 countries. Earlier in his career, Mr. Stadil was an investment banker at Barclays in London and in the treasury function at DONG Energy.
Mr. Stadil has a B.Sc in economics and business administration as well as an M.Sc in finance and management accounting from Copenhagen Business School.
About Unimed
Unimed is the industry leader in medical supply, equipment and oxygen distribution to global maritime industries, specializing in the delivery of integrated healthcare and safety supply chain logistical solutions to clients worldwide.
Unimed is a portfolio company of Z Capital Partners, L.L.C., the private equity arm of Z Capital Group, L.L.C. (“ZCG”) (www.zcg.com), a leading privately held merchant bank.
For more information, please visit https://universalmarinemedical.com/.
About ZCG
ZCG is a leading, privately held merchant bank comprised of private markets asset management, business consulting services, technology development and solutions.
For almost 30 years, ZCG Principals have invested tens of billions in capital and have industry leading track records in private equity and credit.
ZCG has approximately $7B of AUM in asset management and its investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.
ZCG has a global team comprised of over 400 professionals. For more information, please visit www.zcg.com.
